Processa Pharmaceuticals (PCSA) had the highest return in 2014 by a US stock in the Biotechnology Industry, returning 1,796,566.7%.

ASSET	YEAR	% RETURN
Processa Pharmaceuticals (PCSA)	2014	1,796,566.67%
Tempest Therapeutics (TPST)	2014	384.34%
Agios Pharm (AGIO)	2014	371.15%
TG Therapeutics (TGTX)	2014	300%
Amicus Therapeutics (FOLD)	2014	254.04%
PTC Therapeutics (PTCT)	2014	209.44%
Esperion Therapeutics (ESPR)	2014	192.83%
Atara Biotherapeutics (ATRA)	2014	170.48%
Skye Bioscience, Inc Common Stock (SKYE)	2014	158.33%
Fennec Pharmaceuticals (FENC)	2014	149.07%
Neurocrine Biosciences (NBIX)	2014	140.99%
EXACT Sciences (EXAS)	2014	135.94%
Immunic (IMUX)	2014	103.51%
iBio, Inc Common Stock (IBIO)	2014	97.14%
Xenon Pharmaceuticals (XENE)	2014	97.11%
Arbutus Biopharma (ABUS)	2014	90.57%
Enanta Pharmaceuticals (ENTA)	2014	85.65%
Puma Biotechnology (PBYI)	2014	83.95%
Lexaria Bioscience (LEXX)	2014	75.62%
PharmaCyte Biotech (PMCB)	2014	71.92%
Xencor (XNCR)	2014	70.82%
Travere Therapeutics (TVTX)	2014	70.24%
Myriad Genetics (MYGN)	2014	62.81%
BioCryst Pharmaceuticals (BCRX)	2014	61.06%
Vertex Pharmaceuticals (VRTX)	2014	60.39%